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Abstract Haploinsufficiency of the human 5q35 region
spanning the NSD1 gene results in a rare genomic disorder
known as Sotos syndrome (Sotos), with patients displaying
a variety of clinical features, including pre- and postnatal
overgrowth, intellectual disability, and urinary/renal
abnormalities. We used chromosome engineering to gen-
erate a segmental monosomy, i.e., mice carrying a het-
erozygous 1.5-Mb deletion of 36 genes on mouse
chromosome 13 (4732471D19Rik-B4galt7), syntenic with
5q35.2–q35.3 in humans (Df(13)Ms2Dja?/- mice). Sur-
prisingly Df(13)Ms2Dja?/- mice were significantly smaller
for their gestational age and also showed decreased
postnatal growth, in contrast to Sotos patients.
Df(13)Ms2Dja?/- mice did, however, display deficits in
long-term memory retention and dilation of the pelvicaly-
ceal system, which in part may model the learning diffi-
culties and renal abnormalities observed in Sotos patients.
Thus, haploinsufficiency of genes within the mouse
4732471D19Rik–B4galt7 deletion interval play important
roles in growth, memory retention, and the development of
the renal pelvicalyceal system.
Introduction
Sotos syndrome (Sotos; MIM# 117550) is an autosomal
dominant, multiple-anomaly syndrome characterized by
overgrowth, a distinctive craniofacial appearance,
advanced bone age, and variable learning disabilities.
However, there is significant clinical heterogeneity in Sotos
syndrome, with some affected individuals also showing
frequent ear and chest infections, cardiac and urinary/renal
defects, seizures, scoliosis, and behavioural problems
(Tatton-Brown et al. 1993). The diagnosis of Sotos syn-
drome relied solely on clinical criteria until haploinsuffi-
ciency of the NSD1 gene (encoding a histone
methyltransferase implicated in chromatin regulation) was
identified as causative (Kurotaki et al. 2002). Subsequent
analysis of patients clinically diagnosed with Sotos showed
that haploinsufficiency of NSD1 due to intragenic NSD1
mutations, partial NSD1 deletions, or chromosomal mic-
rodeletions spanning the 5q35 region encompassing the
entire NSD1 gene accounted for more than 90 % of cases
(with the prevalence of intragenic NSD1 mutations and
5q35 microdeletions encompassing the NSD1 gene
depending greatly on ethnic origin) (Baujat et al. 2004;
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Tatton-Brown and Rahman 2007; Tatton-Brown et al.
2005a, b). It has also been proposed that GPC3 mutations or
11p15 abnormalities or both may be responsible for some
Sotos cases without NSD1 abnormalities (Baujat et al. 2004;
Li et al. 2001; Tatton-Brown and Rahman 2007).
The major clinical features of Sotos, including over-
growth, facial abnormalities, and intellectual disabilities,
are diagnosed in Sotos patients with intragenic NSD1
mutations and in Sotos individuals carrying 5q35 mic-
rodeletions (Tatton-Brown et al. 2005a, b). However, in
contrast to Sotos individuals with NSD1 mutations, Sotos
patients with 5q35 microdeletions tend to show less pro-
nounced overgrowth but more profound intellectual dis-
ability (Kurotaki et al. 2003; Nagai et al. 2003; Saugier-
Veber et al. 2007; Tatton-Brown et al. 2005a), and several
studies have reported an increased frequency of cardio-
vascular and urinary/renal abnormalities in 5q35 microde-
letion Sotos patients (Kurotaki et al. 2003; Nagai et al.
2003; Saugier-Veber et al. 2007). Thus, it is possible that
genes other than the NSD1 gene could be dosage-sensitive
and therefore responsible for the extended variability and
degree of severity of phenotypes observed in Sotos patients
who carry 5q35 microdeletions. Furthermore, selected
patients with Sotos can have low laboratory values of the
factor XII blood-clotting protein, a phenotype thought to
result from the hemizygous deletion of 5q35, unmasking a
functional single nucleotide variant (SNV) on the remaining
nondeleted allele of the FXII gene within the common Sotos
deletion interval (Kurotaki et al. 2005). The latter genetic
mechanism has recently also been shown to be responsible
for TAR (thrombocytopenia absent radius) syndrome where
1q21.1 deletions appear to unmask functional variants
associated with the RBM8a gene (Albers et al. 2012).
The mouse orthologue of the NSD1 gene (Nsd1) is highly
conserved (83 % homology at amino acid level) (Kurotaki
et al. 2001); however, heterozygous Nsd1 mice do not dis-
play any gross phenotypic abnormalities (Rayasam et al.
2003). Similarly, mice carrying knockout mutations of other
genes within the most frequently detected human Sotos 5q35
microdeletion interval have failed to display dominant phe-
notypes, suggesting that Sncb, Unc5a, Fgfr4, Mxd3, Rgs14,
Slc34a1, F12, Grk6, Dbn1, and Dok3 are not dosage-sensi-
tive and, therefore, at least individually are not likely to be
responsible for the extended variability and degree of
severity of clinical features observed in 5q35 microdeletion
Sotos patients (Mouse Genome Informatics; http://www.
informatics.jax.org). In order to allow investigation of the
contribution of the 36 genes at the distal end of human
chromosome 5 to the development of clinical features
commonly diagnosed in Sotos patients, we used chromo-
some engineering to generate a new genetic mouse model of
Sotos syndrome, Df(13)Ms2Dja?/-, carrying a deletion
syntenic to the human chromosome 5q35.2–q35.3 region.
Materials and methods
Gene targeting in ES cells and generation of deletion
mice
The 50 Hprt MICER targeting vector MHPN55m07 (Adams
et al. 2004) was linearized with KpnI and electroporated into
E14Tg2a embryonic stem (ES) cells (129P2Ola), which were
selected in G418 as described previously (Ramirez-Solis et al.
1995). Southern blotting was performed on BstEII-digested ES
cell genomic DNA (gDNA) using a probe amplified from
E14Tg2a gDNA (50-GTC TGT TGT TAA AAG CTA AAA
CCT TAG A-30 and 50-TGA GCT ACA GTT TGG TTC TGG
TGG ATA AAC-30) to identify correctly targeted clones. The
30 Hprt MICER targeting vector MHPP265c24 (Adams et al.
2004) was linearized with NcoI and electroporated into
MHPN55m07-targeted E14Tg2a ES cells, which were then
selected in puromycin. Southern blotting was performed on
SpeI-digested gDNA using a probe amplified from E14Tg2a
gDNA (50-CAG TAA TAT AGT AGA AGC ATG GTC CAT-
30 and 50-ATG ATA CTG AAC ACA GAC AAC AGA GGC
TGC T-30). Double-targeted ES cell clones were electropora-
ted with a Cre-expression vector and selected in hypoxanthine,
aminopterin, and thymidine (HAT) medium, as described
previously (Ramirez-Solis et al. 1995), to identify whether the
50 Hprt and 30 Hprt vectors were targeted in cis or in trans.
Clones of ES cells that had undergone cis recombination were
identified and confirmed by PCR (50-AAG GGT GTT TAT
TCC CCA TGG ACT AAT TAT G-30 and 50-CCT TCA TCA
CAT CTC GAG CAA GAC GTT CAG-30; presence of a 1.7-kb
band confirmed the cis orientation). The deletion allele was
designated Df(13)Ms2Dja. ES cell clones carrying the con-
ditional deletion (prior to electroporation with Cre) were
injected into C57BL/6-Tyrc-Brd blastocysts and transmitted
through the germline. F1 mice carrying the conditional dele-
tion were bred with CMV-Cre mice (Su et al. 2002) to gen-
erate heterozygous Df(13)Ms2Dja mice (Df(13)Ms2Dja?/-).
These deficiency mice, Df(13)Ms2Dja?/-, were backcrossed
to C57BL/6J for three to four generations and maintained on
a mixed C57BL/6J-129P2Ola background. All mice were
housed and experimental procedures were carried out in
accordance with UK Home Office guidelines.
Comparative genomic hybridization (CGH)
CGH analysis was performed on the Agilent 244A array
using tail DNA. The data were processed and analysed in R
(R Foundation for Statistical Computing, Vienna, Austria).
Fluorescent in situ hybridization (FISH)
Chromosome spreads of activated splenocytes and ES
cells were generated and labelled as described previously
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(Migdalska et al. 2012; Robertson 1987). Mouse BAC clones
(http://bacpac.chori.org/mmouse24.htm) were located inside
(RP23-99C7) or outside (RP24-204D5) the deletion region
and labelled with DIG-dUTP or biotin-dUTP, respectively.
Histology
Tissues were fixed in 10 % neutral buffered formalin for
24 h and embedded in paraffin; then 5-mm sections were
cut and stained with haematoxylin and eosin.
Phenotypic assays
Body weight and length analysis
Embryos were weighed at day 15.5 of gestation (E15.5),
and mice were weighed at 1 day, or 10, 28, or 52 weeks of
age. The body length measurements were taken at 10 and
28 weeks of age.
Dual-energy X-ray absorptiometry (DEXA)
Mice at 10 or 28 weeks of age were analysed on a PIXImus
II Densitometer (GE Medical Systems, Buckingshire, UK)
as described previously (Migdalska et al. 2012). Data were
statistically analysed using the two-tailed Student’s t-test.
X-ray imaging
Mice at 28 and 52 weeks of age were euthanized and
assessed using the MX20 Faxitron system (Faxitron Bi-
optics, LLC, Lincolnshire, IL). Two lateral X-ray images
were acquired: a whole-body image and a lower abdominal
image. The latter images were analysed to check for the
presence of stones in the kidneys.
Behavioural tests
Mice were group-housed from weaning age (3 weeks) and
behavioural tests performed at 22–28 weeks of age. All mice
were prehandled for 1–2 min every day for 4 days prior to
testing for habituation. Two tests were performed, specifically
a social recognition test and an olfactory/vomeronasal func-
tion test, both as previously described (Migdalska et al. 2012).
Results
Generation of Df(13)Ms2Dja?/- mice carrying a 1.5-
Mb deletion of the 4732471D19Rik–B4galt7 region
The 4732471D19Rik and B4galt7 genes are located at the
proximal and distal ends of a 1.5-Mb region in the B1 band
of mouse chromosome 13 (MMU13), which is syntenic to
the human cytogenetic region 5q35.2–q35.3 and the
genomic interval Chr 5: 175–177 Mb (Fig. 1a). This region
on human chromosome 5 (HSA5) contains 36 genes (NCBI
build GRChr37), all of which have orthologous counter-
parts found on the syntenic region of MMU13 (NCBI build
m37) (Supplementary Table 1). We used chromosomal
engineering to generate the deletion (Zheng et al. 1999),
whereby E14Tg2a ES cells were sequentially electropora-
ted with targeting vectors containing a portion of the Hprt
selection cassette (50 or 30 Hprt), a loxP site, and a coat-
colour marker (Agouti or Tyrosinase). The targeting vector
containing the 50 Hprt cassette (MICER clone:
MHPN55m07) (Adams et al. 2004) was inserted proximal
to 4732471D19Rik and the targeting vector containing the
30 Hprt cassette (MICER clone: MHPP265c24) (Adams
et al. 2004) was inserted distal to B4galt7 (Fig. 1b). The
correct insertion of both targeting vectors was confirmed
by Southern blot analysis on BstEII- or SpeI-digested
genomic DNA extracted from ES clones using external
probes. Double-targeted ES cell clones were electroporated
with a Cre-expression vector and selected in medium
containing hypoxanthine, aminopterin, and thymidine
(HAT) to identify lines carrying chromosomal deletions
generated via loxP-mediated recombination. Clones in
which the vectors were targeted in cis generated hundreds
of colonies, while those targeted in trans generated vir-
tually no colonies. The deletion allele was designated
Df(13)Ms2Dja, and deletion of the interval between the
targeting vectors was confirmed by fluorescence in situ
hybridisation (FISH) on Hprt-resistant ES clones
(Fig. 1d). Cis-targeted conditional ES cell clones were
injected and the double-targeted un-recombined (floxed)
chromosome was transmitted through the germline. The
resulting F1 mice were bred with a Cre deleter strain
(CMV-Cre mice) to generate Df(13)Ms2Dja?/- mice.
Df(13)Ms2Dja?/- mice were backcrossed to C57BL/6J
for three to four generations and maintained on a mixed
C57BL/6J-129P2/Ola background. FISH analysis was
performed on splenocytes, as described above, to revali-
date the allele before experiments were performed using
Df(13)Ms2Dja?/- mice. CGH analysis of tail DNA also
confirmed the establishment of the Df(13)Ms2Dja deletion
in mice (Fig. 1c).
Df(13)Ms2Dja?/- embryos are small for their
gestational age
To determine whether clinical features of Sotos patients
could be observed in Df(13)Ms2Dja?/- mice, we initiated
our studies during embryonic development. At embryonic
day 15.5 (E15.5), Df(13)Ms2Dja?/- embryos showed sig-
nificantly reduced growth (as measured by reduced body
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weight) for their gestational age when compared with wild-
type littermate embryos (Fig. 2a). It is unlikely that this
difference is due to the genetic background of these mice
(mixed C57–129), as the same phenotype was observed
after a one-generation backcross to different strains (spe-
cifically, BALB/cJ, CBA/J, and 129/S5SvEv; Supplemen-
tary Fig. 1). Reduced growth of Df(13)Ms2Dja?/- animals
was also evident upon examination of 1-day-old pups
compared with wild-type littermates (Fig. 2b). These
observations are contrary to human Sotos foetuses and
newborns that typically show an overt overgrowth pheno-
type and suggest differences in the role that NSD1 and
Nsd1 play in embryonic and postnatal development in
human and mouse, respectively.
Adult Df(13)Ms2Dja?/- mice are smaller and lighter
than their littermates
Df(13)Ms2Dja?/- mice fed on a normal-fat diet were
lighter and shorter than their wild-type littermates at
28 weeks (males, Fig. 2c, d; females, data not shown).
Detailed analysis of the body composition of these mice
revealed a statistically significant decrease in the lean
mass, but not fat mass, of Df(13)Ms2Dja?/- mice (males,
Fig. 2e, f; females, data not shown).
In addition, to determine whether clinical features of
Sotos patients, including macrocephaly, facial abnormali-
ties, hypotonia, seizures, and/or scoliosis, could be observed
in adult Df(13)Ms2Dja?/- mice, they were subjected to
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Fig. 1 Generation of a 1.5-Mb deletion between the 4732471D19Rik
and B4galt7 loci. a Schematic representation of HSA5 and the
syntenic region on MMU13 with the end points of the syntenic
regions indicated (4732471D19Rik and B4galt7). Genes that map to
the human 5q35.2–q35.3 region (NCBI build GRChr37) and the B1
band on MMU13 (NCBI build m37) are listed in Supplementary
Table 1. b The targeting vectors used to generate the 1.5-Mb deletion
between the 4732471D19Rik and B4galt7 loci contained a loxP site
(arrowhead), a selectable antibiotic resistance gene [N (neomycin) or
P (puromycin)], a coat-colour marker (Ty or Ag), and part of the Hprt
gene (50 or 30), which were targeted as indicated (B, BstEII; S, SpeI; P,
puromycin; N, neomycin; Ty, Tyrosinase; Ag, Agouti). c Comparative
genomic hybridization of the Sotos deletion interval. d Interphase
FISH analysis with BAC probes that map either inside (green) or
outside of (red) the deletion interval. Chromosomes from the ES cells
double-targeted in cis (Df(13)Ms2Dja?/-) showed a red signal
indicating deletion of the 4732471D19Rik-B4galt7 interval (*), while
the wild-type chromosome showed red and green signals (**). There
are two additional green centromeric signals present due to nonspe-
cific binding of the probe
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dysmorphology and X-ray analysis. However, Df(13)Ms2Dja?/-
mice were viable, fertile, and did not show any overt skeletal
or craniofacial phenotypes (data not shown).
Behavioural phenotyping of adult Df(13)Ms2Dja?/-
mice
To identify whether the learning disability of Sotos patients
could be observed in adult Df(13)Ms2Dja?/- mice, the
mice were subjected to two olfactory discrimination tests
(social recognition paradigms with a long-term memory
component) (Engelmann et al. 2011). A ‘‘habituation-dish-
abituation’’ test showed that deficiency mice were similar to
wild-type littermates in their ability to recognize two dif-
ferent stimulus animals, as shown by the decline in the
investigation time over trials 1–4 when they were repeti-
tively presented the same animal (mouse A), and an increase
in the investigation time on trial 5 when they were presented
with a novel stimulus animal (mouse B) (Fig. 3a; two-way
ANOVA with repeated measures for Trial, P \ 0.0001, and
post-hoc test trial 4 vs. trial 5, P \ 0.0001). Both groups of
mice had similar initial levels of investigation and spent
increasingly less amounts of time investigating the repeat-
edly presented stimulus animal, suggesting normal levels of
anxiety and social olfactory-mediated interaction for
Df(13)Ms2Dja?/- animals. However, the ‘‘discrimination
test’’ showed that deficiency mice were less capable of dis-
tinguishing the familiar stimulus animal (mouse A) 24 h
later (two-way ANOVA with repeated measures, effect of
Genotype, P = 0.045). They spent a significantly longer
time investigating the familiar mouse than did the wild-type
littermate controls (Fig. 3b; Bonferroni post-hoc test wild-
type vs. Df(13)Ms2Dja?/- mice, P \ 0.05). To confirm
that this deficit was cognitive and not simply a conse-
quence of diminished olfactory/vomeronasal capacity in
Df(13)Ms2Dja?/- mice, we ascertained that they could
recognize and discriminate between signature odours in the
absence of other sensory cues with ability equal to that of
their wild-type littermates (Supplementary Fig. 2). Thus,
Df(13)Ms2Dja?/- mice show a degree of learning disability.
Histopathological analysis of Df(13)Ms2Dja?/- mice
reveals dilation of the renal pelvicalyceal system
To determine whether histopathological abnormalities of
Sotos patients, in particular, advanced bone age, cardio-
vascular, and/or urinary/renal abnormalities, could be
observed in Df(13)Ms2Dja?/- mice, they were subjected to
histopathological analysis at 10 weeks of age. Examination
of a variety of tissues stained with haematoxylin and
eosin (H&E) failed to reveal the presence of anatomical
abnormalities of any organs, except the kidneys, where
dilation of the pelvicalyceal system was observed in
Df(13)Ms2Dja?/- mice with 100 % penetrance (Fig. 4a).
Kidney and urinary abnormalities are diagnosed in
approximately 10 % of Sotos patients, suggesting that
kidney abnormalities are a highly penetrant trait recapitu-
lated in Df(13)Ms2Dja?/- mice. Interestingly, a range in
the severity of the pelvicalyceal system dilatation (mild
through moderate to severe) was observed, and in all cases
of moderate or severe dilation, only one kidney was
affected moderately or severely while the other kidney
showed only mild dilation. This dilation did not progress
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Fig. 2 Phenotypic analysis of Df(13)Ms2Dja?/- mice at various time
points. a Body weight measurements in control (?/?, n = 12) and
deficiency (Df(13)Ms2Dja?/-, n = 12) littermates at embryonic day
15.5. b Body weight measurements in control (?/?, n = 25) and
deficiency (Df(13)Ms2Dja?/-, n = 21) littermates at 1 day of age. c,
d Body weight and length measurements in control (?/?, n = 12)
and deficiency (Df(13)Ms2Dja?/-, n = 11) littermates at 28 weeks of
age. e, f DEXA analysis of lean mass and fat mass in control (?/?,
n = 12) and deficiency (Df(13)Ms2Dja?/-, n = 11) littermates at
28 weeks of age. All data were statistically analysed using the two-
tailed Student’s t-test, and the asterisk indicates statistical signifi-
cance. The error bars represent the standard deviation of the
measurements
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with age, as the same range of changes observed in
10-week-old mice was also present in 28-week-old
(Fig. 4b) and 52-week-old (Fig. 4c) deficiency mice. Blood
chemistry analysis revealed no significant change in
parameters related to urinary/renal system clearance and
metabolic functioning, including creatinine, urea, and
electrolytes in 28- and 52-week-old Df(13)Ms2Dja?/-
mice when compared to wild-type littermate controls (data
not shown). This suggests that dilation of the pelvicalyceal
system does not affect overall kidney function. X-ray
analysis at 28 and 52 weeks of age revealed the absence of
kidney stones in Df(13)Ms2Dja?/- mice (data not shown).
Discussion
We generated and phenotypically characterized the het-
erozygous deficiency Df(13)Ms2Dja mouse—a genetic
model of Sotos syndrome covering a 1.5-Mb region syn-
tenic to the telomeric part of human chromosome 5. This
region contains 36 genes, which are conserved between
human and mouse (Fig. 1). Df(13)Ms2Dja?/- mice were
viable, fertile, and indistinguishable from wild-type litter-
mate controls in terms of head and facial morphology,
muscle tone, and curvature of their spine. Thus,
Df(13)Ms2Dja?/- mice do not recapitulate the macro-
cephaly, facial abnormalities, hypotonia, or scoliosis
observed in some Sotos patients (Tatton-Brown and Rah-
man 2007). However, it is difficult to reliably model facial
abnormalities in mice (Tobin et al. 2008). Sotos individuals
have facial abnormalities that include a high and broad
forehead (the head is said to resemble an inverted pear),
frontotemporal hair sparsity, malar flushing, down-slanting
palpebral fissures, and a pointed chin, dysmorphology that
is probably hard to observe in mice.
Deficiency mice fed on a normal-fat diet did, however,
show significantly reduced growth at all time points mea-
sured (embryonic day 15.5–52 weeks of age; Fig. 2). The
presence of reduced postnatal growth in Df(13)Ms2Dja?/-
mice contrasts with human data, as Sotos patients with
intragenic NSD1 mutations and those with 5q35 microde-
letions encompassing the NSD1 gene exhibit overgrowth
(Tatton-Brown and Rahman 2007). However, the over-
growth phenotype observed in Sotos patients with 5q35
microdeletions is not very pronounced, even at the early
stages of development (Kurotaki et al. 2003; Nagai et al.
2003; Saugier-Veber et al. 2007; Tatton-Brown and Rahman
2007). Collectively, these data suggest divergent roles for
Nsd1/NSD1 in regulating growth in mouse and man.
Df(13)Ms2Dja?/- mice showed deficits in long-term
memory retention in a socially relevant testing paradigm
(Fig. 3). In contrast to other artificial novel object dis-
crimination assays, the mechanism of long-term social
recognition in mice is multisensory, requiring the integra-
tion of both volatile and nonvolatile olfactory and phero-
mone cues from conspecifics (Noack et al. 2010).
Moreover, the sensitivity of the assay is enhanced by its
ethological relevance; it does not rely on prior conditioning
and instead exploits an innate olfactory-mediated behav-
ioural response of rodents (Engelmann et al. 2011). Social
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Fig. 3 Learning impairment in Df(13)Ms2Dja?/- mice.
a Habituation-dishabituation test. Both deficiency (Df(13)Ms2Dja?/-,
n = 9) and control (?/?, n = 8) mice recognized two different
stimulus animals, as shown by a decline in the investigation time over
trials 1–4 when they were repetitively presented the same stimulus
animal (mouse A), and an increase in the investigation time on trial 5
when they were presented with a novel stimulus animal (mouse B)
(trial 4 vs. trial 5, P \ 0.0001, post-hoc analysis after two-way
ANOVA). b Discrimination test (performed 24 h after the
habituation-dishabituation test). Df(13)Ms2Dja?/- mice spent signif-
icantly more time investigating the familiar stimulus mouse (mouse
A) than did control mice (P \ 0.05, two-tailed Student’s t-test),
suggesting that Df(13)Ms2Dja?/- mice were less able to distinguish a
familiar from an unfamiliar animal (mouse C). The error bars
represent the standard error of the mean and the asterisks indicate
statistical significance. Four animals (one deficiency and three wild
types) were withdrawn from the experiment because of their low
investigation times (less than 10 s on trial 1)
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recognition is hippocampus-dependent (Kogan et al. 2000)
and is well established for learning and memory testing
(Engelmann et al. 2011; Richter et al. 2005) and for
assessing cognitive impairment in mice (Mitsui et al.
2009). Thus, Df(13)Ms2Dja?/- mice may potentially
model the intellectual/learning disability observed in Sotos
syndrome patients (Tatton-Brown et al. 2005b). Given that
the 4732471D19Rik-B4galt7 region spans 36 genes, it is
possible that other genes within the interval might, in
addition to Nsd1, contribute to the cognitive phenotype
observed in Df(13)Ms2Dja?/- mice.
Histopathological examination of tissues from
Df(13)Ms2Dja?/- mice revealed no signs of advanced bone
age or cardiovascular anomalies, although these abnormalities
A
+/+
B
C
*
*
* *
*
* *
*
* * * *
Df(13)Ms2Dja+/- Df(13)Ms2Dja+/- Df(13)Ms2Dja+/-
Fig. 4 Dilation of the renal pelvicalyceal system in
Df(13)Ms2Dja?/- mice. Haematoxylin and eosin-stained kidney
sections from control (?/?) and deficiency (Df(13)Ms2Dja?/-) mice
at a 10 weeks, b 28 weeks, and c 52 weeks of age. Kidneys of
deficiency (Df(13)Ms2Dja?/-) mice showed mild through moderate
to severe dilation of the pelvicalyceal system (left to right) (visible as
empty spaces; indicated by asterisks) compared with control litter-
mates (normal structure of the pelvicalyceal system indicated by
asterisks). Images are representative and taken at 9250 magnification
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are observed only in a subset of Sotos patients carrying 5q35
microdeletions (Nagai et al. 2003; Saugier-Veber et al. 2007;
Tatton-Brown and Rahman 2007). However, kidney abnor-
malities were observed in our deficiency animals, specifically
dilation of the pelvicalyceal system (Fig. 4). Anomalies of the
urinary/renal system, including vesicoureteric reflux, hydro-
nephrosis, and small kidneys, are diagnosed in some (*10 %)
Sotos patients carrying 5q35 microdeletions (Kurotaki et al.
2003; Nagai et al. 2003; Saugier-Veber et al. 2007; Tatton-
Brown and Rahman 2007). Hydronephrosis is characterized
by dilation of the renal pelvis and calyces, so
Df(13)Ms2Dja?/- mice seem to recapitulate key features of
this anomaly. To date, no mice carrying knockout mutations in
genes mapped within the 5q35 interval have been shown to
exhibit dilation of the pelvicalyceal system, suggesting that
Sncb, Unc5a, Nsd1, Fgfr4, Mxd3, Rgs14, Slc34a1, F12, Grk6,
Dbn1, and Dok3 are unlikely, at least individually, to con-
tribute to this phenotype in Df(13)Ms2Dja?/- mice (Mouse
Genome Informatics, http://www.informatics.jax.org). How-
ever, it is possible that haploinsufficiency of other genes in the
interval may contribute with Nsd1 to the renal organ system
anomalies observed in Sotos patients and Df(13)Ms2Dja?/-
mice. Synergy between genes within copy number variable
regions has recently been demonstrated for cardiac develop-
ment anomalies associated with Down syndrome (Grossman
et al. 2011) and postulated for other genomic disorders
(Lupski et al. 2011).
We show here that haploinsufficiency of gene(s) in the
4732471D19Rik-B4galt7 region of MMU13, syntenic to
human 5q35.2–q35.3, results in pre- and postnatal under-
growth, cognitive impairment, and dilation of the renal
pelvicalyceal system in Df(13)Ms2Dja?/- mice. Thus,
Df(13)Ms2Dja?/- mice have contributed new insights into
the role that genes within the Sotos syndrome deletion
interval play in Sotos-associated intellectual disability,
growth, and development of the urinary/renal system.
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